VOICED : Perú inicia ensayos en 6.000 voluntarios de vacuna china contra covid-19

The clinical trials for a COVID-19 vaccine by Sinopharm have started in Peru, involving 6,000 volunteers. Two universities, Cayetano Heredia and San Marcos, are overseeing the trials. Volunteers, aged 18-75, were selected quickly online. The trial uses a double-blind method, with groups receiving either the Wuhan strain, Beijing strain, or a placebo. A Chinese scientific mission is supervising the project, expected to conclude in December. Peru, heavily impacted by COVID-19, is the third in Latin America for pandemic-related deaths.

Which universities are responsible for the COVID-19 vaccine trials in Peru?

• University of San Marcos and University of Peru

• University of Lima and Cayetano Heredia University

• Cayetano Heredia University and University of San Marcos

• University of Lima and University of San Marcos

What was the age requirement for volunteers in the vaccine trial?

• 18 to 75 years

• 18 to 60 years

• 25 to 70 years

• 21 to 65 years

How many volunteers signed up for the trial within three hours?

• 15,000

• 12,000

• 9,000

• 6,000

What is the purpose of the double-blind method in the vaccine trial?

• To ensure only the volunteers know what they receive

• To prevent bias by keeping both volunteers and administrators unaware of the treatment given

• To ensure only the administrators know what is being administered

• To allow the administrators to know the treatment but not the volunteers

Which strain of the vaccine is NOT being tested in the trial?

• Shanghai strain

• Beijing strain

• Wuhan strain

• Placebo